Markets:

Overview

News

Currencies

International

Treasuries

Cigna Corp (NY:CI)

281.21 +5.96 (+2.17%)

Streaming Delayed Price Updated: 1:18 PM EDT, Aug 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cigna Corp

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

42 43 Next >

Price Over Earnings Overview: Cigna ↗

November 19, 2024

Via Benzinga

Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul ↗

November 17, 2024

Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 12, 2024

Via Benzinga

Why Cigna Stock Popped Today ↗

November 11, 2024

The healthcare company put merger rumors to bed.

Via The Motley Fool

3 Healthcare Stocks For Long-Term Growth And Dividends ↗

November 07, 2024

Healthcare stocks will profit from the U.S. aging population and pay rising dividends over time.

Via Talk Markets

Price Over Earnings Overview: Cigna ↗

November 04, 2024

Via Benzinga

NYSE:CI is an undervalued gem with solid fundamentals. ↗

October 28, 2024

THE CIGNA GROUP (NYSE:CI): good value for what you're paying.

Via Chartmill

Cigna’s Stock Surges After Dropping Humana Merger Plans ↗

November 11, 2024

Cigna Group has decided not to merge with Humana, leading to a rise in Cigna's stock and a drop in Humana's stock.

Via Talk Markets

MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday ↗

November 11, 2024

Via Benzinga

Cigna Not Pursuing Humana Merger, Stock Soars ↗

November 11, 2024

Cigna Group reaffirms 2024 EPS outlook, reports strong Q3 results, and clarifies it is not pursuing a merger with Humana amid ongoing speculation.

Via Benzinga

Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare ↗

November 09, 2024

Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.

Via Benzinga

Topics Government

Investors seeking growth at a reasonable cost should explore NYSE:CI. ↗

October 28, 2024

THE CIGNA GROUP (NYSE:CI) is showing good growth, while it is not too expensive.

Via Chartmill

11 Analysts Assess Cigna: What You Need To Know ↗

October 23, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Cigna Stock In The Last 15 Years ↗

October 23, 2024

Via Benzinga

Boomer Benefits Unveils Revamped 6-Day Mini-Course on Medicare

November 05, 2024

Fort Worth, Texas--(Newsfile Corp. - November 5, 2024) - Boomer Benefits, a leading Medicare insurance agency based in Fort Worth,...

Via Newsfile

MarketBeat Week in Review – 10/28 - 11/1

November 02, 2024

Stocks staged a strong rally on Friday following a steep sell-off; a weak jobs report all but guarantees a rate cut which adds to bullish sentiment

Via MarketBeat

Topics Artificial Intelligence Economy

Cigna Group (CI) Q3 2024 Earnings Call Transcript ↗

October 31, 2024

CI earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Cigna's Q3 Profit Beats Street On Strong Demand For Pharmacy Benefit Management's Specialty Drugs, New Clients ↗

October 31, 2024

Cigna reports Q3 sales of $63.7 billion, a 30% YoY increase, driven by Evernorth growth. Adjusted EPS of $7.51 beats estimates. 2024 EPS guidance reaffirmed.

Via Benzinga

Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday? ↗

October 31, 2024

Risk aversion swept across markets on Thursday as investor disappointment over third-quarter tech earnings triggered the steepest drop in major U.S. indices in nearly two months.

Via Benzinga

The Cigna Group Reports $63.7 Billion In Q3 Total Revenues, Better Than Expected ↗

October 31, 2024

The Cigna Group has reported impressive financial results for the third quarter of 2024.

Via Talk Markets

Cigna Considers Humana Acquisition – What It Means for the Stocks

October 29, 2024

Rumors swirl around a potential Cigna (CI) and Humana (HUM) merger, but Medicare Advantage costs pose a significant challenge, making the merger risky.

Via MarketBeat

Jim Cramer: Buy Broadcom, But Stay Away From These Stocks ↗

October 25, 2024

The "Mad Money" host recommends buying Broadcom, but staying away from this bus manufacturer. "I just don't see the growth."

Via Benzinga

Why Cigna Group Stock Got Mashed on Monday ↗

October 21, 2024

A media report stated that the company is determined to grow with a major merger deal.

Via The Motley Fool

Stocks Fall As Treasury Yields, Dollar Rise; Nvidia Hits Record Highs: What's Driving Markets Monday? ↗

October 21, 2024

U.S. major indices fell on Monday as rising Treasury yields and a strengthening dollar dampened risk sentiment. Investors are reassessing the economic outlook and weighing potential risks tied to the...

Via Benzinga

Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms ↗

October 21, 2024

Cigna and Humana are in early-stage merger discussions after a year-long pause. Amid financial pressure, Humana's Medicare Advantage star ratings have plummeted, impacting future revenue.

Via Benzinga

Cigna-Humana Merger Talks Back On With Tables Turned; 2024 Election Is Key ↗

October 21, 2024

Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled.

Via Investor's Business Daily

Market Briefing For Monday, Oct 21 ↗

October 21, 2024

Investors need to recognize that this time of year not only are more 'shakeouts' than we've seen likely; but tax-selling and shuffling (rearranging the Titanic deckchairs to some degree) is to be...

Via Talk Markets

SAP, Nucor And 3 Stocks To Watch Heading Into Monday ↗

October 21, 2024

Via Benzinga

Pharmacy Retailer CVS Health Backs Away From Annual Forecast, Names New CEO ↗

October 18, 2024

CVS Health replaces CEO Karen Lynch with David Joyner as the company struggles with lower earnings projections and rising medical costs. Q3 2024 results, including a $1.1 billion charge, are expected...

Via Benzinga

CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit ↗

October 09, 2024

The FTC has filed a formal complaint accusing CVS, Cigna, and UnitedHealth of engaging in anti-competitive practices that inflate insulin prices. The complaint claims the PBMs' focus on rebates raises...

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

42 43 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.